nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—ABCB1—colon cancer	0.245	1	CbGaD
Simvastatin—UGT1A1—Irinotecan—colon cancer	0.0705	0.127	CbGbCtD
Simvastatin—SLCO1B1—Irinotecan—colon cancer	0.0488	0.0877	CbGbCtD
Simvastatin—ABCC2—Irinotecan—colon cancer	0.0429	0.077	CbGbCtD
Simvastatin—ABCC2—Vincristine—colon cancer	0.0375	0.0673	CbGbCtD
Simvastatin—CYP3A7—Irinotecan—colon cancer	0.0286	0.0514	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0286	0.0514	CbGbCtD
Simvastatin—SLCO1A2—Methotrexate—colon cancer	0.0274	0.0492	CbGbCtD
Simvastatin—CYP2B6—Irinotecan—colon cancer	0.0273	0.049	CbGbCtD
Simvastatin—SLCO1B1—Methotrexate—colon cancer	0.0258	0.0464	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.025	0.045	CbGbCtD
Simvastatin—CYP3A7—Vincristine—colon cancer	0.025	0.045	CbGbCtD
Simvastatin—CYP2C9—Capecitabine—colon cancer	0.0233	0.0419	CbGbCtD
Simvastatin—ABCC2—Methotrexate—colon cancer	0.0227	0.0408	CbGbCtD
Simvastatin—CYP3A5—Irinotecan—colon cancer	0.0215	0.0386	CbGbCtD
Simvastatin—CYP2C8—Fluorouracil—colon cancer	0.0198	0.0356	CbGbCtD
Simvastatin—CYP3A5—Vincristine—colon cancer	0.0188	0.0337	CbGbCtD
Simvastatin—ABCB1—Irinotecan—colon cancer	0.014	0.0251	CbGbCtD
Simvastatin—CYP2C9—Fluorouracil—colon cancer	0.0138	0.0248	CbGbCtD
Simvastatin—ABCB1—Vincristine—colon cancer	0.0122	0.022	CbGbCtD
Simvastatin—CYP3A4—Irinotecan—colon cancer	0.00838	0.015	CbGbCtD
Simvastatin—ABCB1—Methotrexate—colon cancer	0.0074	0.0133	CbGbCtD
Simvastatin—CYP3A4—Vincristine—colon cancer	0.00732	0.0132	CbGbCtD
Simvastatin—ITGB2—endothelium—colon cancer	0.00668	0.104	CbGeAlD
Simvastatin—ABCC2—bile—colon cancer	0.00541	0.084	CbGeAlD
Simvastatin—ITGB2—epithelium—colon cancer	0.003	0.0465	CbGeAlD
Simvastatin—ITGB2—lymphoid tissue—colon cancer	0.00231	0.0358	CbGeAlD
Simvastatin—ITGB2—digestive system—colon cancer	0.00228	0.0354	CbGeAlD
Simvastatin—ITGB2—bone marrow—colon cancer	0.0021	0.0326	CbGeAlD
Simvastatin—HMGCR—gall bladder—colon cancer	0.00207	0.0321	CbGeAlD
Simvastatin—ITGB2—vagina—colon cancer	0.00201	0.0312	CbGeAlD
Simvastatin—UGT1A3—digestive system—colon cancer	0.00192	0.0298	CbGeAlD
Simvastatin—ITGB2—liver—colon cancer	0.0017	0.0264	CbGeAlD
Simvastatin—UGT1A3—liver—colon cancer	0.00143	0.0222	CbGeAlD
Simvastatin—UGT2B7—renal system—colon cancer	0.00134	0.0209	CbGeAlD
Simvastatin—ITGB2—lymph node—colon cancer	0.0013	0.0202	CbGeAlD
Simvastatin—UGT1A1—renal system—colon cancer	0.00114	0.0177	CbGeAlD
Simvastatin—UGT2B7—digestive system—colon cancer	0.0011	0.0171	CbGeAlD
Simvastatin—HMGCR—epithelium—colon cancer	0.00107	0.0166	CbGeAlD
Simvastatin—HMGCR—smooth muscle tissue—colon cancer	0.00103	0.016	CbGeAlD
Simvastatin—Pravastatin—ABCB1—colon cancer	0.00101	0.5	CrCbGaD
Simvastatin—Lovastatin—ABCB1—colon cancer	0.00101	0.5	CrCbGaD
Simvastatin—HMGCR—renal system—colon cancer	0.000992	0.0154	CbGeAlD
Simvastatin—SLCO1B1—renal system—colon cancer	0.000951	0.0148	CbGeAlD
Simvastatin—UGT1A1—digestive system—colon cancer	0.000937	0.0145	CbGeAlD
Simvastatin—CYP3A7—liver—colon cancer	0.000847	0.0131	CbGeAlD
Simvastatin—HMGCR—lymphoid tissue—colon cancer	0.000824	0.0128	CbGeAlD
Simvastatin—UGT2B7—liver—colon cancer	0.000821	0.0127	CbGeAlD
Simvastatin—HMGCR—digestive system—colon cancer	0.000814	0.0126	CbGeAlD
Simvastatin—SLCO1B1—digestive system—colon cancer	0.00078	0.0121	CbGeAlD
Simvastatin—SLCO1A2—renal system—colon cancer	0.000774	0.012	CbGeAlD
Simvastatin—HMGCR—bone marrow—colon cancer	0.00075	0.0116	CbGeAlD
Simvastatin—ABCC2—renal system—colon cancer	0.000721	0.0112	CbGeAlD
Simvastatin—CYP3A7-CYP3A51P—liver—colon cancer	0.00072	0.0112	CbGeAlD
Simvastatin—HMGCR—vagina—colon cancer	0.000719	0.0112	CbGeAlD
Simvastatin—UGT1A1—liver—colon cancer	0.000698	0.0108	CbGeAlD
Simvastatin—SLCO1A2—digestive system—colon cancer	0.000635	0.00985	CbGeAlD
Simvastatin—HMGCR—liver—colon cancer	0.000606	0.00941	CbGeAlD
Simvastatin—ABCC2—digestive system—colon cancer	0.000591	0.00917	CbGeAlD
Simvastatin—SLCO1B1—liver—colon cancer	0.000581	0.00901	CbGeAlD
Simvastatin—ABCB1—blood vessel—colon cancer	0.000574	0.00891	CbGeAlD
Simvastatin—CYP2C8—renal system—colon cancer	0.000541	0.00839	CbGeAlD
Simvastatin—CYP2C19—digestive system—colon cancer	0.000508	0.00788	CbGeAlD
Simvastatin—CYP3A5—renal system—colon cancer	0.000488	0.00757	CbGeAlD
Simvastatin—CYP2B6—renal system—colon cancer	0.000485	0.00752	CbGeAlD
Simvastatin—SLCO1A2—liver—colon cancer	0.000473	0.00734	CbGeAlD
Simvastatin—HMGCR—lymph node—colon cancer	0.000465	0.00721	CbGeAlD
Simvastatin—CYP2C19—vagina—colon cancer	0.000449	0.00696	CbGeAlD
Simvastatin—ABCC2—liver—colon cancer	0.00044	0.00683	CbGeAlD
Simvastatin—Depression—Vincristine—colon cancer	0.000429	0.00517	CcSEcCtD
Simvastatin—Proteinuria—Methotrexate—colon cancer	0.000424	0.00512	CcSEcCtD
Simvastatin—Neuropathy peripheral—Vincristine—colon cancer	0.000421	0.00509	CcSEcCtD
Simvastatin—Sleep disorder—Capecitabine—colon cancer	0.00042	0.00507	CcSEcCtD
Simvastatin—Protein urine present—Methotrexate—colon cancer	0.000418	0.00505	CcSEcCtD
Simvastatin—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.000418	0.00505	CcSEcCtD
Simvastatin—Diabetes mellitus—Capecitabine—colon cancer	0.000418	0.00505	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000418	0.00504	CcSEcCtD
Simvastatin—Hepatic function abnormal—Capecitabine—colon cancer	0.000416	0.00502	CcSEcCtD
Simvastatin—Photosensitivity—Capecitabine—colon cancer	0.000414	0.005	CcSEcCtD
Simvastatin—Swelling—Capecitabine—colon cancer	0.000412	0.00497	CcSEcCtD
Simvastatin—Photosensitivity reaction—Fluorouracil—colon cancer	0.00041	0.00495	CcSEcCtD
Simvastatin—Jaundice—Irinotecan—colon cancer	0.000408	0.00493	CcSEcCtD
Simvastatin—Vascular purpura—Capecitabine—colon cancer	0.000406	0.00491	CcSEcCtD
Simvastatin—Hepatic failure—Capecitabine—colon cancer	0.000405	0.00488	CcSEcCtD
Simvastatin—Haemolytic anaemia—Capecitabine—colon cancer	0.000403	0.00486	CcSEcCtD
Simvastatin—CYP2B6—lymphoid tissue—colon cancer	0.000403	0.00625	CbGeAlD
Simvastatin—CYP3A5—digestive system—colon cancer	0.0004	0.00621	CbGeAlD
Simvastatin—CYP2B6—digestive system—colon cancer	0.000398	0.00617	CbGeAlD
Simvastatin—CYP2C9—digestive system—colon cancer	0.000394	0.00611	CbGeAlD
Simvastatin—Neuropathy peripheral—Fluorouracil—colon cancer	0.000393	0.00474	CcSEcCtD
Simvastatin—CYP2C8—vagina—colon cancer	0.000392	0.00608	CbGeAlD
Simvastatin—Amnesia—Capecitabine—colon cancer	0.000387	0.00467	CcSEcCtD
Simvastatin—Inflammation—Methotrexate—colon cancer	0.000384	0.00464	CcSEcCtD
Simvastatin—Atrial fibrillation—Capecitabine—colon cancer	0.000384	0.00463	CcSEcCtD
Simvastatin—Vasculitis—Methotrexate—colon cancer	0.000382	0.00461	CcSEcCtD
Simvastatin—CYP2C19—liver—colon cancer	0.000378	0.00587	CbGeAlD
Simvastatin—Purpura—Capecitabine—colon cancer	0.000377	0.00455	CcSEcCtD
Simvastatin—Sinusitis—Fluorouracil—colon cancer	0.000376	0.00454	CcSEcCtD
Simvastatin—Arthritis—Capecitabine—colon cancer	0.000374	0.00452	CcSEcCtD
Simvastatin—CYP3A4—renal system—colon cancer	0.000366	0.00568	CbGeAlD
Simvastatin—CYP2D6—renal system—colon cancer	0.00036	0.00559	CbGeAlD
Simvastatin—CYP3A5—vagina—colon cancer	0.000353	0.00548	CbGeAlD
Simvastatin—CYP2B6—vagina—colon cancer	0.000351	0.00545	CbGeAlD
Simvastatin—Flushing—Irinotecan—colon cancer	0.000349	0.00421	CcSEcCtD
Simvastatin—ABCB1—embryo—colon cancer	0.000342	0.00531	CbGeAlD
Simvastatin—Alopecia—Vincristine—colon cancer	0.000341	0.00412	CcSEcCtD
Simvastatin—Mental disorder—Vincristine—colon cancer	0.000338	0.00408	CcSEcCtD
Simvastatin—ABCC2—lymph node—colon cancer	0.000338	0.00524	CbGeAlD
Simvastatin—Chills—Irinotecan—colon cancer	0.000337	0.00407	CcSEcCtD
Simvastatin—Gynaecomastia—Methotrexate—colon cancer	0.000334	0.00403	CcSEcCtD
Simvastatin—Alopecia—Irinotecan—colon cancer	0.000332	0.00401	CcSEcCtD
Simvastatin—CYP2C8—liver—colon cancer	0.00033	0.00513	CbGeAlD
Simvastatin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000327	0.00395	CcSEcCtD
Simvastatin—Flatulence—Irinotecan—colon cancer	0.000322	0.00389	CcSEcCtD
Simvastatin—Gastritis—Capecitabine—colon cancer	0.000322	0.00388	CcSEcCtD
Simvastatin—Muscular weakness—Capecitabine—colon cancer	0.000321	0.00387	CcSEcCtD
Simvastatin—Alopecia—Fluorouracil—colon cancer	0.000318	0.00384	CcSEcCtD
Simvastatin—Muscle spasms—Irinotecan—colon cancer	0.000314	0.0038	CcSEcCtD
Simvastatin—Erythema—Fluorouracil—colon cancer	0.000313	0.00378	CcSEcCtD
Simvastatin—Diabetes mellitus—Methotrexate—colon cancer	0.000311	0.00376	CcSEcCtD
Simvastatin—Anaemia—Vincristine—colon cancer	0.00031	0.00375	CcSEcCtD
Simvastatin—Photosensitivity—Methotrexate—colon cancer	0.000308	0.00372	CcSEcCtD
Simvastatin—Ill-defined disorder—Irinotecan—colon cancer	0.000304	0.00366	CcSEcCtD
Simvastatin—Anaemia—Irinotecan—colon cancer	0.000302	0.00365	CcSEcCtD
Simvastatin—Bronchitis—Capecitabine—colon cancer	0.000302	0.00365	CcSEcCtD
Simvastatin—Vertigo—Vincristine—colon cancer	0.000302	0.00364	CcSEcCtD
Simvastatin—Abdominal discomfort—Capecitabine—colon cancer	0.000301	0.00364	CcSEcCtD
Simvastatin—Hepatic failure—Methotrexate—colon cancer	0.000301	0.00364	CcSEcCtD
Simvastatin—Leukopenia—Vincristine—colon cancer	0.000301	0.00363	CcSEcCtD
Simvastatin—CYP3A4—digestive system—colon cancer	0.0003	0.00466	CbGeAlD
Simvastatin—CYP3A5—liver—colon cancer	0.000298	0.00463	CbGeAlD
Simvastatin—CYP2B6—liver—colon cancer	0.000296	0.0046	CbGeAlD
Simvastatin—CYP2D6—digestive system—colon cancer	0.000296	0.00459	CbGeAlD
Simvastatin—Vision blurred—Fluorouracil—colon cancer	0.000295	0.00356	CcSEcCtD
Simvastatin—Malaise—Irinotecan—colon cancer	0.000295	0.00356	CcSEcCtD
Simvastatin—Vertigo—Irinotecan—colon cancer	0.000294	0.00355	CcSEcCtD
Simvastatin—CYP2C9—liver—colon cancer	0.000293	0.00455	CbGeAlD
Simvastatin—Leukopenia—Irinotecan—colon cancer	0.000293	0.00353	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Capecitabine—colon cancer	0.000292	0.00353	CcSEcCtD
Simvastatin—Anaemia—Fluorouracil—colon cancer	0.00029	0.0035	CcSEcCtD
Simvastatin—Photosensitivity reaction—Capecitabine—colon cancer	0.000287	0.00346	CcSEcCtD
Simvastatin—Myalgia—Vincristine—colon cancer	0.000286	0.00345	CcSEcCtD
Simvastatin—Leukopenia—Fluorouracil—colon cancer	0.00028	0.00339	CcSEcCtD
Simvastatin—ABCB1—epithelium—colon cancer	0.000279	0.00434	CbGeAlD
Simvastatin—Depression—Capecitabine—colon cancer	0.000279	0.00337	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000278	0.00335	CcSEcCtD
Simvastatin—Discomfort—Irinotecan—colon cancer	0.000275	0.00332	CcSEcCtD
Simvastatin—Neuropathy peripheral—Capecitabine—colon cancer	0.000275	0.00332	CcSEcCtD
Simvastatin—Anaphylactic shock—Vincristine—colon cancer	0.000274	0.00331	CcSEcCtD
Simvastatin—Oedema—Vincristine—colon cancer	0.000274	0.00331	CcSEcCtD
Simvastatin—Jaundice—Capecitabine—colon cancer	0.000273	0.0033	CcSEcCtD
Simvastatin—Infection—Vincristine—colon cancer	0.000272	0.00329	CcSEcCtD
Simvastatin—Confusional state—Irinotecan—colon cancer	0.000269	0.00325	CcSEcCtD
Simvastatin—Thrombocytopenia—Vincristine—colon cancer	0.000268	0.00324	CcSEcCtD
Simvastatin—Anaphylactic shock—Irinotecan—colon cancer	0.000267	0.00322	CcSEcCtD
Simvastatin—Oedema—Irinotecan—colon cancer	0.000267	0.00322	CcSEcCtD
Simvastatin—Myalgia—Fluorouracil—colon cancer	0.000267	0.00322	CcSEcCtD
Simvastatin—Chest pain—Fluorouracil—colon cancer	0.000267	0.00322	CcSEcCtD
Simvastatin—Infection—Irinotecan—colon cancer	0.000265	0.0032	CcSEcCtD
Simvastatin—Discomfort—Fluorouracil—colon cancer	0.000264	0.00318	CcSEcCtD
Simvastatin—Thrombocytopenia—Irinotecan—colon cancer	0.000261	0.00316	CcSEcCtD
Simvastatin—Anorexia—Vincristine—colon cancer	0.000261	0.00315	CcSEcCtD
Simvastatin—ABCB1—renal system—colon cancer	0.000259	0.00402	CbGeAlD
Simvastatin—Confusional state—Fluorouracil—colon cancer	0.000258	0.00311	CcSEcCtD
Simvastatin—Oedema—Fluorouracil—colon cancer	0.000256	0.00309	CcSEcCtD
Simvastatin—Anaphylactic shock—Fluorouracil—colon cancer	0.000256	0.00309	CcSEcCtD
Simvastatin—Anorexia—Irinotecan—colon cancer	0.000254	0.00307	CcSEcCtD
Simvastatin—Infection—Fluorouracil—colon cancer	0.000254	0.00307	CcSEcCtD
Simvastatin—Hepatitis—Capecitabine—colon cancer	0.000251	0.00304	CcSEcCtD
Simvastatin—Thrombocytopenia—Fluorouracil—colon cancer	0.00025	0.00302	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Vincristine—colon cancer	0.00025	0.00301	CcSEcCtD
Simvastatin—Insomnia—Vincristine—colon cancer	0.000248	0.00299	CcSEcCtD
Simvastatin—Paraesthesia—Vincristine—colon cancer	0.000246	0.00297	CcSEcCtD
Simvastatin—Anorexia—Fluorouracil—colon cancer	0.000244	0.00294	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000244	0.00294	CcSEcCtD
Simvastatin—Insomnia—Irinotecan—colon cancer	0.000241	0.00291	CcSEcCtD
Simvastatin—Paraesthesia—Irinotecan—colon cancer	0.00024	0.00289	CcSEcCtD
Simvastatin—Decreased appetite—Vincristine—colon cancer	0.000238	0.00288	CcSEcCtD
Simvastatin—Dyspnoea—Irinotecan—colon cancer	0.000238	0.00287	CcSEcCtD
Simvastatin—Erythema multiforme—Capecitabine—colon cancer	0.000238	0.00287	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Vincristine—colon cancer	0.000237	0.00286	CcSEcCtD
Simvastatin—Fatigue—Vincristine—colon cancer	0.000236	0.00285	CcSEcCtD
Simvastatin—Dyspepsia—Irinotecan—colon cancer	0.000235	0.00284	CcSEcCtD
Simvastatin—Pain—Vincristine—colon cancer	0.000234	0.00283	CcSEcCtD
Simvastatin—Constipation—Vincristine—colon cancer	0.000234	0.00283	CcSEcCtD
Simvastatin—Flushing—Capecitabine—colon cancer	0.000233	0.00282	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000233	0.00281	CcSEcCtD
Simvastatin—Decreased appetite—Irinotecan—colon cancer	0.000232	0.0028	CcSEcCtD
Simvastatin—Eosinophilia—Methotrexate—colon cancer	0.000232	0.0028	CcSEcCtD
Simvastatin—Insomnia—Fluorouracil—colon cancer	0.000231	0.00279	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Irinotecan—colon cancer	0.00023	0.00278	CcSEcCtD
Simvastatin—Fatigue—Irinotecan—colon cancer	0.00023	0.00278	CcSEcCtD
Simvastatin—Paraesthesia—Fluorouracil—colon cancer	0.00023	0.00277	CcSEcCtD
Simvastatin—Pancreatitis—Methotrexate—colon cancer	0.000229	0.00277	CcSEcCtD
Simvastatin—Constipation—Irinotecan—colon cancer	0.000228	0.00276	CcSEcCtD
Simvastatin—Pain—Irinotecan—colon cancer	0.000228	0.00276	CcSEcCtD
Simvastatin—Dyspnoea—Fluorouracil—colon cancer	0.000228	0.00275	CcSEcCtD
Simvastatin—Chills—Capecitabine—colon cancer	0.000226	0.00272	CcSEcCtD
Simvastatin—Dyspepsia—Fluorouracil—colon cancer	0.000225	0.00272	CcSEcCtD
Simvastatin—Abdominal discomfort—Methotrexate—colon cancer	0.000224	0.00271	CcSEcCtD
Simvastatin—Gastrointestinal pain—Vincristine—colon cancer	0.000224	0.00271	CcSEcCtD
Simvastatin—CYP3A4—liver—colon cancer	0.000224	0.00347	CbGeAlD
Simvastatin—Decreased appetite—Fluorouracil—colon cancer	0.000222	0.00268	CcSEcCtD
Simvastatin—Alopecia—Capecitabine—colon cancer	0.000222	0.00268	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000221	0.00266	CcSEcCtD
Simvastatin—Mental disorder—Capecitabine—colon cancer	0.00022	0.00266	CcSEcCtD
Simvastatin—CYP2D6—liver—colon cancer	0.00022	0.00342	CbGeAlD
Simvastatin—Feeling abnormal—Irinotecan—colon cancer	0.00022	0.00266	CcSEcCtD
Simvastatin—Erythema—Capecitabine—colon cancer	0.000219	0.00264	CcSEcCtD
Simvastatin—Pain—Fluorouracil—colon cancer	0.000219	0.00264	CcSEcCtD
Simvastatin—Gastrointestinal pain—Irinotecan—colon cancer	0.000218	0.00264	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Methotrexate—colon cancer	0.000217	0.00262	CcSEcCtD
Simvastatin—Abdominal pain—Vincristine—colon cancer	0.000217	0.00262	CcSEcCtD
Simvastatin—Body temperature increased—Vincristine—colon cancer	0.000217	0.00262	CcSEcCtD
Simvastatin—Flatulence—Capecitabine—colon cancer	0.000216	0.0026	CcSEcCtD
Simvastatin—Erectile dysfunction—Methotrexate—colon cancer	0.000215	0.0026	CcSEcCtD
Simvastatin—ABCB1—lymphoid tissue—colon cancer	0.000215	0.00334	CbGeAlD
Simvastatin—Dysgeusia—Capecitabine—colon cancer	0.000214	0.00259	CcSEcCtD
Simvastatin—Photosensitivity reaction—Methotrexate—colon cancer	0.000213	0.00258	CcSEcCtD
Simvastatin—ABCB1—digestive system—colon cancer	0.000213	0.0033	CbGeAlD
Simvastatin—Abdominal pain—Irinotecan—colon cancer	0.000211	0.00255	CcSEcCtD
Simvastatin—Body temperature increased—Irinotecan—colon cancer	0.000211	0.00255	CcSEcCtD
Simvastatin—Feeling abnormal—Fluorouracil—colon cancer	0.000211	0.00254	CcSEcCtD
Simvastatin—Muscle spasms—Capecitabine—colon cancer	0.00021	0.00254	CcSEcCtD
Simvastatin—Depression—Methotrexate—colon cancer	0.000208	0.00251	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000207	0.0025	CcSEcCtD
Simvastatin—Vision blurred—Capecitabine—colon cancer	0.000206	0.00249	CcSEcCtD
Simvastatin—Tremor—Capecitabine—colon cancer	0.000205	0.00248	CcSEcCtD
Simvastatin—Ill-defined disorder—Capecitabine—colon cancer	0.000203	0.00245	CcSEcCtD
Simvastatin—Urticaria—Fluorouracil—colon cancer	0.000203	0.00245	CcSEcCtD
Simvastatin—Anaemia—Capecitabine—colon cancer	0.000202	0.00244	CcSEcCtD
Simvastatin—Body temperature increased—Fluorouracil—colon cancer	0.000202	0.00244	CcSEcCtD
Simvastatin—Hypersensitivity—Vincristine—colon cancer	0.000202	0.00244	CcSEcCtD
Simvastatin—Malaise—Capecitabine—colon cancer	0.000197	0.00238	CcSEcCtD
Simvastatin—Vertigo—Capecitabine—colon cancer	0.000197	0.00237	CcSEcCtD
Simvastatin—Hypersensitivity—Irinotecan—colon cancer	0.000197	0.00237	CcSEcCtD
Simvastatin—Asthenia—Vincristine—colon cancer	0.000197	0.00237	CcSEcCtD
Simvastatin—Leukopenia—Capecitabine—colon cancer	0.000196	0.00237	CcSEcCtD
Simvastatin—ABCB1—bone marrow—colon cancer	0.000196	0.00304	CbGeAlD
Simvastatin—Asthenia—Irinotecan—colon cancer	0.000192	0.00231	CcSEcCtD
Simvastatin—Hypersensitivity—Fluorouracil—colon cancer	0.000188	0.00227	CcSEcCtD
Simvastatin—ABCB1—vagina—colon cancer	0.000188	0.00291	CbGeAlD
Simvastatin—Diarrhoea—Vincristine—colon cancer	0.000188	0.00226	CcSEcCtD
Simvastatin—Hepatitis—Methotrexate—colon cancer	0.000187	0.00226	CcSEcCtD
Simvastatin—Myalgia—Capecitabine—colon cancer	0.000186	0.00225	CcSEcCtD
Simvastatin—Arthralgia—Capecitabine—colon cancer	0.000186	0.00225	CcSEcCtD
Simvastatin—Chest pain—Capecitabine—colon cancer	0.000186	0.00225	CcSEcCtD
Simvastatin—Anxiety—Capecitabine—colon cancer	0.000186	0.00224	CcSEcCtD
Simvastatin—Discomfort—Capecitabine—colon cancer	0.000184	0.00222	CcSEcCtD
Simvastatin—Diarrhoea—Irinotecan—colon cancer	0.000183	0.00221	CcSEcCtD
Simvastatin—Dizziness—Vincristine—colon cancer	0.000181	0.00219	CcSEcCtD
Simvastatin—Pruritus—Fluorouracil—colon cancer	0.000181	0.00218	CcSEcCtD
Simvastatin—Confusional state—Capecitabine—colon cancer	0.00018	0.00217	CcSEcCtD
Simvastatin—Oedema—Capecitabine—colon cancer	0.000179	0.00216	CcSEcCtD
Simvastatin—Infection—Capecitabine—colon cancer	0.000178	0.00214	CcSEcCtD
Simvastatin—Erythema multiforme—Methotrexate—colon cancer	0.000177	0.00214	CcSEcCtD
Simvastatin—Dizziness—Irinotecan—colon cancer	0.000177	0.00213	CcSEcCtD
Simvastatin—Diarrhoea—Fluorouracil—colon cancer	0.000175	0.00211	CcSEcCtD
Simvastatin—Thrombocytopenia—Capecitabine—colon cancer	0.000175	0.00211	CcSEcCtD
Simvastatin—Vomiting—Vincristine—colon cancer	0.000174	0.0021	CcSEcCtD
Simvastatin—Rash—Vincristine—colon cancer	0.000173	0.00209	CcSEcCtD
Simvastatin—Dermatitis—Vincristine—colon cancer	0.000173	0.00208	CcSEcCtD
Simvastatin—Headache—Vincristine—colon cancer	0.000172	0.00207	CcSEcCtD
Simvastatin—Anorexia—Capecitabine—colon cancer	0.00017	0.00206	CcSEcCtD
Simvastatin—Vomiting—Irinotecan—colon cancer	0.00017	0.00205	CcSEcCtD
Simvastatin—Dizziness—Fluorouracil—colon cancer	0.000169	0.00204	CcSEcCtD
Simvastatin—Rash—Irinotecan—colon cancer	0.000168	0.00203	CcSEcCtD
Simvastatin—Dermatitis—Irinotecan—colon cancer	0.000168	0.00203	CcSEcCtD
Simvastatin—Chills—Methotrexate—colon cancer	0.000168	0.00203	CcSEcCtD
Simvastatin—Headache—Irinotecan—colon cancer	0.000167	0.00202	CcSEcCtD
Simvastatin—Alopecia—Methotrexate—colon cancer	0.000165	0.002	CcSEcCtD
Simvastatin—Mental disorder—Methotrexate—colon cancer	0.000164	0.00198	CcSEcCtD
Simvastatin—Erythema—Methotrexate—colon cancer	0.000163	0.00197	CcSEcCtD
Simvastatin—Nausea—Vincristine—colon cancer	0.000163	0.00197	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000163	0.00197	CcSEcCtD
Simvastatin—Vomiting—Fluorouracil—colon cancer	0.000163	0.00196	CcSEcCtD
Simvastatin—Insomnia—Capecitabine—colon cancer	0.000162	0.00195	CcSEcCtD
Simvastatin—Rash—Fluorouracil—colon cancer	0.000161	0.00195	CcSEcCtD
Simvastatin—Dermatitis—Fluorouracil—colon cancer	0.000161	0.00194	CcSEcCtD
Simvastatin—Paraesthesia—Capecitabine—colon cancer	0.00016	0.00194	CcSEcCtD
Simvastatin—Headache—Fluorouracil—colon cancer	0.00016	0.00193	CcSEcCtD
Simvastatin—Dysgeusia—Methotrexate—colon cancer	0.00016	0.00193	CcSEcCtD
Simvastatin—Dyspnoea—Capecitabine—colon cancer	0.000159	0.00192	CcSEcCtD
Simvastatin—Nausea—Irinotecan—colon cancer	0.000159	0.00191	CcSEcCtD
Simvastatin—ABCB1—liver—colon cancer	0.000158	0.00246	CbGeAlD
Simvastatin—Dyspepsia—Capecitabine—colon cancer	0.000157	0.0019	CcSEcCtD
Simvastatin—Decreased appetite—Capecitabine—colon cancer	0.000155	0.00187	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000154	0.00186	CcSEcCtD
Simvastatin—Fatigue—Capecitabine—colon cancer	0.000154	0.00186	CcSEcCtD
Simvastatin—Vision blurred—Methotrexate—colon cancer	0.000154	0.00185	CcSEcCtD
Simvastatin—Pain—Capecitabine—colon cancer	0.000153	0.00184	CcSEcCtD
Simvastatin—Constipation—Capecitabine—colon cancer	0.000153	0.00184	CcSEcCtD
Simvastatin—Nausea—Fluorouracil—colon cancer	0.000152	0.00183	CcSEcCtD
Simvastatin—Ill-defined disorder—Methotrexate—colon cancer	0.000151	0.00183	CcSEcCtD
Simvastatin—Anaemia—Methotrexate—colon cancer	0.000151	0.00182	CcSEcCtD
Simvastatin—Feeling abnormal—Capecitabine—colon cancer	0.000147	0.00178	CcSEcCtD
Simvastatin—Malaise—Methotrexate—colon cancer	0.000147	0.00177	CcSEcCtD
Simvastatin—Vertigo—Methotrexate—colon cancer	0.000146	0.00177	CcSEcCtD
Simvastatin—Gastrointestinal pain—Capecitabine—colon cancer	0.000146	0.00176	CcSEcCtD
Simvastatin—Leukopenia—Methotrexate—colon cancer	0.000146	0.00176	CcSEcCtD
Simvastatin—Urticaria—Capecitabine—colon cancer	0.000142	0.00171	CcSEcCtD
Simvastatin—Body temperature increased—Capecitabine—colon cancer	0.000141	0.00171	CcSEcCtD
Simvastatin—Abdominal pain—Capecitabine—colon cancer	0.000141	0.00171	CcSEcCtD
Simvastatin—Myalgia—Methotrexate—colon cancer	0.000139	0.00167	CcSEcCtD
Simvastatin—Arthralgia—Methotrexate—colon cancer	0.000139	0.00167	CcSEcCtD
Simvastatin—Chest pain—Methotrexate—colon cancer	0.000139	0.00167	CcSEcCtD
Simvastatin—Discomfort—Methotrexate—colon cancer	0.000137	0.00165	CcSEcCtD
Simvastatin—Confusional state—Methotrexate—colon cancer	0.000134	0.00162	CcSEcCtD
Simvastatin—Anaphylactic shock—Methotrexate—colon cancer	0.000133	0.00161	CcSEcCtD
Simvastatin—Infection—Methotrexate—colon cancer	0.000132	0.0016	CcSEcCtD
Simvastatin—Hypersensitivity—Capecitabine—colon cancer	0.000132	0.00159	CcSEcCtD
Simvastatin—Thrombocytopenia—Methotrexate—colon cancer	0.00013	0.00157	CcSEcCtD
Simvastatin—Asthenia—Capecitabine—colon cancer	0.000128	0.00155	CcSEcCtD
Simvastatin—Anorexia—Methotrexate—colon cancer	0.000127	0.00153	CcSEcCtD
Simvastatin—Pruritus—Capecitabine—colon cancer	0.000126	0.00153	CcSEcCtD
Simvastatin—Diarrhoea—Capecitabine—colon cancer	0.000122	0.00148	CcSEcCtD
Simvastatin—ABCB1—lymph node—colon cancer	0.000121	0.00188	CbGeAlD
Simvastatin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000121	0.00146	CcSEcCtD
Simvastatin—Insomnia—Methotrexate—colon cancer	0.00012	0.00145	CcSEcCtD
Simvastatin—Paraesthesia—Methotrexate—colon cancer	0.000119	0.00144	CcSEcCtD
Simvastatin—Dyspnoea—Methotrexate—colon cancer	0.000119	0.00143	CcSEcCtD
Simvastatin—Dizziness—Capecitabine—colon cancer	0.000118	0.00143	CcSEcCtD
Simvastatin—Dyspepsia—Methotrexate—colon cancer	0.000117	0.00141	CcSEcCtD
Simvastatin—Decreased appetite—Methotrexate—colon cancer	0.000116	0.0014	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000115	0.00139	CcSEcCtD
Simvastatin—Fatigue—Methotrexate—colon cancer	0.000115	0.00138	CcSEcCtD
Simvastatin—Pain—Methotrexate—colon cancer	0.000114	0.00137	CcSEcCtD
Simvastatin—Vomiting—Capecitabine—colon cancer	0.000114	0.00137	CcSEcCtD
Simvastatin—Rash—Capecitabine—colon cancer	0.000113	0.00136	CcSEcCtD
Simvastatin—Dermatitis—Capecitabine—colon cancer	0.000113	0.00136	CcSEcCtD
Simvastatin—Headache—Capecitabine—colon cancer	0.000112	0.00135	CcSEcCtD
Simvastatin—Feeling abnormal—Methotrexate—colon cancer	0.00011	0.00132	CcSEcCtD
Simvastatin—Gastrointestinal pain—Methotrexate—colon cancer	0.000109	0.00131	CcSEcCtD
Simvastatin—Nausea—Capecitabine—colon cancer	0.000106	0.00128	CcSEcCtD
Simvastatin—Urticaria—Methotrexate—colon cancer	0.000106	0.00128	CcSEcCtD
Simvastatin—Abdominal pain—Methotrexate—colon cancer	0.000105	0.00127	CcSEcCtD
Simvastatin—Body temperature increased—Methotrexate—colon cancer	0.000105	0.00127	CcSEcCtD
Simvastatin—Hypersensitivity—Methotrexate—colon cancer	9.8e-05	0.00118	CcSEcCtD
Simvastatin—Asthenia—Methotrexate—colon cancer	9.54e-05	0.00115	CcSEcCtD
Simvastatin—Pruritus—Methotrexate—colon cancer	9.41e-05	0.00114	CcSEcCtD
Simvastatin—Diarrhoea—Methotrexate—colon cancer	9.1e-05	0.0011	CcSEcCtD
Simvastatin—Dizziness—Methotrexate—colon cancer	8.8e-05	0.00106	CcSEcCtD
Simvastatin—Vomiting—Methotrexate—colon cancer	8.46e-05	0.00102	CcSEcCtD
Simvastatin—Rash—Methotrexate—colon cancer	8.39e-05	0.00101	CcSEcCtD
Simvastatin—Dermatitis—Methotrexate—colon cancer	8.38e-05	0.00101	CcSEcCtD
Simvastatin—Headache—Methotrexate—colon cancer	8.33e-05	0.00101	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	8.2e-05	0.00168	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CD8A—colon cancer	7.95e-05	0.00163	CbGpPWpGaD
Simvastatin—Nausea—Methotrexate—colon cancer	7.9e-05	0.000954	CcSEcCtD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	7.76e-05	0.00159	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—ODC1—colon cancer	7.69e-05	0.00157	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CHST5—colon cancer	7.69e-05	0.00157	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—colon cancer	7.55e-05	0.00154	CbGpPWpGaD
Simvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	7.53e-05	0.00154	CbGpPWpGaD
Simvastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	7.48e-05	0.00153	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—colon cancer	7.38e-05	0.00151	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—EP300—colon cancer	7.19e-05	0.00147	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—SRC—colon cancer	7e-05	0.00143	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—KRAS—colon cancer	6.97e-05	0.00143	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—CTNNB1—colon cancer	6.97e-05	0.00143	CbGpPWpGaD
Simvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.95e-05	0.00142	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—VEGFA—colon cancer	6.81e-05	0.00139	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—CDKN1A—colon cancer	6.81e-05	0.00139	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—BCL2L1—colon cancer	6.81e-05	0.00139	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—NRAS—colon cancer	6.73e-05	0.00138	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—ODC1—colon cancer	6.7e-05	0.00137	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CHST5—colon cancer	6.7e-05	0.00137	CbGpPWpGaD
Simvastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	6.67e-05	0.00137	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—CDKN1A—colon cancer	6.54e-05	0.00134	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	6.53e-05	0.00134	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—FGFR3—colon cancer	6.51e-05	0.00133	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—EP300—colon cancer	6.48e-05	0.00133	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CA7—colon cancer	6.42e-05	0.00131	CbGpPWpGaD
Simvastatin—UGT1A3—NRF2 pathway—TGFB1—colon cancer	6.31e-05	0.00129	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—SRC—colon cancer	6.3e-05	0.00129	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CA7—colon cancer	6.27e-05	0.00128	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—TGFB1—colon cancer	6.25e-05	0.00128	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—ODC1—colon cancer	6.25e-05	0.00128	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CHST5—colon cancer	6.25e-05	0.00128	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—colon cancer	6.2e-05	0.00127	CbGpPWpGaD
Simvastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	6.09e-05	0.00125	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—NRAS—colon cancer	6.06e-05	0.00124	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—SRC—colon cancer	6.05e-05	0.00124	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—NRAS—colon cancer	5.82e-05	0.00119	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—KRAS—colon cancer	5.79e-05	0.00119	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ODC1—colon cancer	5.73e-05	0.00117	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CHST5—colon cancer	5.73e-05	0.00117	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—EGFR—colon cancer	5.52e-05	0.00113	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CDH1—colon cancer	5.5e-05	0.00112	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CA7—colon cancer	5.43e-05	0.00111	CbGpPWpGaD
Simvastatin—UGT2B7—NRF2 pathway—TGFB1—colon cancer	5.36e-05	0.0011	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—PIK3CA—colon cancer	5.32e-05	0.00109	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—EGFR—colon cancer	5.3e-05	0.00108	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ODC1—colon cancer	5.26e-05	0.00108	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CHST5—colon cancer	5.26e-05	0.00108	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—colon cancer	5.23e-05	0.00107	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	5.22e-05	0.00107	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—KRAS—colon cancer	5.21e-05	0.00107	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—TP53—colon cancer	5.15e-05	0.00105	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—KRAS—colon cancer	5.01e-05	0.00102	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—HRAS—colon cancer	4.92e-05	0.00101	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CA7—colon cancer	4.85e-05	0.000992	CbGpPWpGaD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	4.8e-05	0.000982	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—PIK3CA—colon cancer	4.79e-05	0.00098	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CA7—colon cancer	4.73e-05	0.000968	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—PIK3CA—colon cancer	4.6e-05	0.000941	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.58e-05	0.000937	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CA7—colon cancer	4.46e-05	0.000912	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—HRAS—colon cancer	4.43e-05	0.000907	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CA7—colon cancer	4.42e-05	0.000905	CbGpPWpGaD
Simvastatin—UGT1A1—NRF2 pathway—TGFB1—colon cancer	4.36e-05	0.000891	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—AKT1—colon cancer	4.35e-05	0.000889	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	4.34e-05	0.000888	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HRAS—colon cancer	4.26e-05	0.000871	CbGpPWpGaD
Simvastatin—ABCC2—NRF2 pathway—TGFB1—colon cancer	4.25e-05	0.00087	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—CASP3—colon cancer	4.19e-05	0.000858	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	4.11e-05	0.000841	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CTNNB1—colon cancer	4.06e-05	0.00083	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	4e-05	0.000819	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CDKN1A—colon cancer	3.96e-05	0.000811	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—AKT1—colon cancer	3.91e-05	0.000801	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ODC1—colon cancer	3.89e-05	0.000795	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CHST5—colon cancer	3.89e-05	0.000795	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.85e-05	0.000789	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CHST5—colon cancer	3.8e-05	0.000777	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ODC1—colon cancer	3.8e-05	0.000777	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—ABCB1—colon cancer	3.78e-05	0.000773	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—EP300—colon cancer	3.77e-05	0.000772	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—AKT1—colon cancer	3.76e-05	0.000769	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—SRC—colon cancer	3.67e-05	0.00075	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.6e-05	0.000737	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—VEGFA—colon cancer	3.56e-05	0.000728	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—NRAS—colon cancer	3.53e-05	0.000722	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	3.44e-05	0.000704	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ODC1—colon cancer	3.29e-05	0.000673	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CHST5—colon cancer	3.29e-05	0.000673	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—TGFB1—colon cancer	3.27e-05	0.000668	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.23e-05	0.000661	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—EGFR—colon cancer	3.21e-05	0.000658	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—KRAS—colon cancer	3.04e-05	0.000621	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—EP300—colon cancer	3e-05	0.000613	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CHST5—colon cancer	2.94e-05	0.000601	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ODC1—colon cancer	2.94e-05	0.000601	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.94e-05	0.000601	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—ABCB1—colon cancer	2.93e-05	0.0006	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CA7—colon cancer	2.92e-05	0.000597	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—TYMS—colon cancer	2.88e-05	0.000589	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ODC1—colon cancer	2.87e-05	0.000587	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CHST5—colon cancer	2.87e-05	0.000587	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—PIK3CA—colon cancer	2.79e-05	0.000571	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.76e-05	0.000566	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ODC1—colon cancer	2.7e-05	0.000553	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CHST5—colon cancer	2.7e-05	0.000553	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CHST5—colon cancer	2.68e-05	0.000548	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ODC1—colon cancer	2.68e-05	0.000548	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.62e-05	0.000537	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—HRAS—colon cancer	2.58e-05	0.000528	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—ABCB1—colon cancer	2.39e-05	0.000489	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.36e-05	0.000484	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—TYMS—colon cancer	2.35e-05	0.00048	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—AKT1—colon cancer	2.28e-05	0.000466	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.23e-05	0.000456	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.22e-05	0.000454	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.17e-05	0.000445	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.07e-05	0.000423	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PPARG—colon cancer	2.04e-05	0.000417	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—ABCB1—colon cancer	2.03e-05	0.000416	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.01e-05	0.000412	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—TYMS—colon cancer	2e-05	0.000408	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2e-05	0.000408	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.95e-05	0.000399	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.86e-05	0.000381	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.85e-05	0.000379	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.81e-05	0.00037	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.8e-05	0.000369	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—ABCB1—colon cancer	1.77e-05	0.000362	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ODC1—colon cancer	1.77e-05	0.000361	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CHST5—colon cancer	1.77e-05	0.000361	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.76e-05	0.000359	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—TYMS—colon cancer	1.74e-05	0.000356	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PPARG—colon cancer	1.66e-05	0.00034	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—ABCB1—colon cancer	1.65e-05	0.000338	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—TYMS—colon cancer	1.62e-05	0.000332	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.62e-05	0.000331	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.61e-05	0.00033	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PTGS2—colon cancer	1.6e-05	0.000328	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.58e-05	0.000323	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.55e-05	0.000316	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ABCB1—colon cancer	1.51e-05	0.00031	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.49e-05	0.000306	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—TYMS—colon cancer	1.49e-05	0.000304	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PPARG—colon cancer	1.41e-05	0.000289	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ABCB1—colon cancer	1.39e-05	0.000284	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.37e-05	0.000281	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—TYMS—colon cancer	1.36e-05	0.000279	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.36e-05	0.000278	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.34e-05	0.000274	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—EP300—colon cancer	1.33e-05	0.000273	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.33e-05	0.000272	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTGS2—colon cancer	1.31e-05	0.000268	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PPARG—colon cancer	1.23e-05	0.000252	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.21e-05	0.000248	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PPARG—colon cancer	1.15e-05	0.000235	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.14e-05	0.000234	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.12e-05	0.000229	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTGS2—colon cancer	1.11e-05	0.000228	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.11e-05	0.000226	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—EP300—colon cancer	1.09e-05	0.000223	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.07e-05	0.000219	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PPARG—colon cancer	1.05e-05	0.000215	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ABCB1—colon cancer	1.03e-05	0.00021	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—TYMS—colon cancer	1.01e-05	0.000206	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ABCB1—colon cancer	1e-05	0.000205	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PIK3CA—colon cancer	9.87e-06	0.000202	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—TYMS—colon cancer	9.86e-06	0.000202	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTGS2—colon cancer	9.69e-06	0.000198	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PPARG—colon cancer	9.66e-06	0.000198	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.54e-06	0.000195	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—EP300—colon cancer	9.25e-06	0.000189	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTGS2—colon cancer	9.04e-06	0.000185	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.89e-06	0.000182	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.7e-06	0.000178	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ABCB1—colon cancer	8.7e-06	0.000178	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—TYMS—colon cancer	8.54e-06	0.000175	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTGS2—colon cancer	8.28e-06	0.000169	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—AKT1—colon cancer	8.07e-06	0.000165	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—EP300—colon cancer	8.06e-06	0.000165	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CA—colon cancer	8.05e-06	0.000165	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.93e-06	0.000162	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ABCB1—colon cancer	7.76e-06	0.000159	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—TYMS—colon cancer	7.62e-06	0.000156	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTGS2—colon cancer	7.6e-06	0.000156	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—EP300—colon cancer	7.52e-06	0.000154	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—TYMS—colon cancer	7.44e-06	0.000152	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.23e-06	0.000148	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PPARG—colon cancer	7.15e-06	0.000146	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ABCB1—colon cancer	7.14e-06	0.000146	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ABCB1—colon cancer	7.08e-06	0.000145	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—TYMS—colon cancer	7.01e-06	0.000143	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PPARG—colon cancer	6.99e-06	0.000143	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—TYMS—colon cancer	6.95e-06	0.000142	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—EP300—colon cancer	6.89e-06	0.000141	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CA—colon cancer	6.84e-06	0.00014	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.58e-06	0.000135	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—AKT1—colon cancer	6.57e-06	0.000135	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—EP300—colon cancer	6.32e-06	0.000129	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PPARG—colon cancer	6.05e-06	0.000124	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CA—colon cancer	5.96e-06	0.000122	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.87e-06	0.00012	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTGS2—colon cancer	5.62e-06	0.000115	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—AKT1—colon cancer	5.59e-06	0.000114	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CA—colon cancer	5.56e-06	0.000114	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTGS2—colon cancer	5.49e-06	0.000112	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PPARG—colon cancer	5.4e-06	0.00011	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.35e-06	0.000109	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PPARG—colon cancer	5.27e-06	0.000108	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CA—colon cancer	5.1e-06	0.000104	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PPARG—colon cancer	4.97e-06	0.000102	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PPARG—colon cancer	4.92e-06	0.000101	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—AKT1—colon cancer	4.87e-06	9.96e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTGS2—colon cancer	4.76e-06	9.74e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CA—colon cancer	4.68e-06	9.57e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—EP300—colon cancer	4.68e-06	9.57e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ABCB1—colon cancer	4.67e-06	9.55e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—TYMS—colon cancer	4.58e-06	9.38e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—EP300—colon cancer	4.57e-06	9.35e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—AKT1—colon cancer	4.54e-06	9.3e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTGS2—colon cancer	4.25e-06	8.69e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—AKT1—colon cancer	4.16e-06	8.52e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTGS2—colon cancer	4.15e-06	8.48e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—EP300—colon cancer	3.96e-06	8.1e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTGS2—colon cancer	3.91e-06	7.99e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTGS2—colon cancer	3.87e-06	7.93e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—AKT1—colon cancer	3.82e-06	7.82e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—EP300—colon cancer	3.53e-06	7.23e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CA—colon cancer	3.46e-06	7.08e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—EP300—colon cancer	3.45e-06	7.06e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CA—colon cancer	3.38e-06	6.92e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—EP300—colon cancer	3.25e-06	6.65e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PPARG—colon cancer	3.25e-06	6.64e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—EP300—colon cancer	3.22e-06	6.59e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CA—colon cancer	2.93e-06	5.99e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—AKT1—colon cancer	2.83e-06	5.78e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—AKT1—colon cancer	2.76e-06	5.65e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CA—colon cancer	2.61e-06	5.35e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTGS2—colon cancer	2.55e-06	5.23e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CA—colon cancer	2.55e-06	5.22e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CA—colon cancer	2.4e-06	4.92e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—AKT1—colon cancer	2.39e-06	4.89e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CA—colon cancer	2.38e-06	4.88e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—AKT1—colon cancer	2.14e-06	4.37e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—EP300—colon cancer	2.12e-06	4.35e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—AKT1—colon cancer	2.08e-06	4.26e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—AKT1—colon cancer	1.96e-06	4.02e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—AKT1—colon cancer	1.95e-06	3.98e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CA—colon cancer	1.57e-06	3.22e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—AKT1—colon cancer	1.28e-06	2.63e-05	CbGpPWpGaD
